Document Detail


Impact of occluder device type on success of percutaneous closure of atrial septal defects--a medium-term follow-up study.
MedLine Citation:
PMID:  19821880     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To identify differences between various occluder types regarding thromboembolic event rates and existence of residual shunts during medium-term follow-up.
METHODS: Three hundred nine consecutive patients with presumed paradoxical embolism and scheduled for percutaneous closure of patent foramen ovale or atrial septal defect between 1997 and 2006 were considered for this study. Device implantation failed in seven patients (nonstable device position), so 302 patients (46 +/- 12 years, 190 males) formed the study group using Amplatzer (n = 208), Starflex (n = 61), and Cardiastar (n = 33) occluders. Follow-up transesophageal echocardiography was performed 1, 3, and 6 months after implantation.
RESULTS: Periinterventional complications occurred in two patients (cardiac arrhythmias). There were more residual shunts in the Starflex and Cardiastar group than in the Amplatzer group at 6-month follow-up (8/61 vs. 7/33 vs. 8/208, P = 0.0005). Performing logistic regression, the type of occluder device was a significant risk factor for the presence of residual shunt 6 months after implantation (P = 0.0033; Cardiastar vs. Amplatzer OR 6.346, 95% CI 1.998 - 20.156; Starflex vs. Amplatzer OR 4.369, 95% CI 1.444 - 13.222). During mean follow-up of 31 +/- 8 months 16 recurrent thromboembolic events occurred; the annual recurrence was 2.1% for combined end-point stroke, TIA, and peripheral embolism (Amplatzer: 1.3%, Starflex: 3.9%, and Cardiastar: 3.6%, P = 0.0467). The presence of an atrial septal aneurysm was the only significant risk factor (P = 0.0168, OR 3.664, 95% CI 1.263 - 10.630) for the occurrence of thromboembolic events.
CONCLUSIONS: Percutaneous closure of patent foramen ovale or atrial septal defect is a safe procedure with little incidence of peri- and postprocedural complications. There is a significant difference between the Amplatzer, Cardiastar, and Starflex occluders in regard to complete closure of the defects and annual recurrence of thromboembolic events.
Authors:
Michael Becker; Dorothee Frings; Jörg Schröder; Christina Ocklenburg; Eberhard Mühler; Rainer Hoffmann; Andreas Franke; Wolfgang Lepper
Publication Detail:
Type:  Journal Article     Date:  2009-10-11
Journal Detail:
Title:  Journal of interventional cardiology     Volume:  22     ISSN:  1540-8183     ISO Abbreviation:  J Interv Cardiol     Publication Date:  2009 Dec 
Date Detail:
Created Date:  2009-12-22     Completed Date:  2011-01-31     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8907826     Medline TA:  J Interv Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  503-10     Citation Subset:  IM    
Affiliation:
University Hospital RWTH Aachen, Department of Cardiology, Aachen, Germany. mibecker@ukaachen.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Analysis of Variance
Balloon Dilation / instrumentation*,  methods
Confidence Intervals
Embolism, Paradoxical / therapy*,  ultrasonography
Female
Foramen Ovale, Patent / therapy,  ultrasonography
Heart Septal Defects, Atrial / therapy*,  ultrasonography
Humans
Logistic Models
Male
Middle Aged
Odds Ratio
Questionnaires
Retrospective Studies
Risk Factors
Septal Occluder Device*
Thromboembolism
Time Factors
Treatment Outcome

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The relationship between intravenous infusate colonisation and fluid container hang time.
Next Document:  Canine platelet transfusions.